Barriers to electronic prescribing of controlled substance, especially opioids

Author:

Borghol AmneORCID,Ahmed Fahamina,Jamero Dana,Calmes Helen,Monthey Taylor,Pappas Stefanie,Scott Rotieranna,Deblieux Joshua S.,Ulrich Melanie,Malhotra Sonia

Abstract

Objective: Electronic prescriptions are now the standard of practice for all discharge and outpatient prescriptions. The intention is to increase patient safety, provide a more complete medication record for patients, lessen the burden on prescribers, and shorten the time it takes for medication orders to reach the pharmacy. Design: This cross-sectional questionnaire survey study was conducted between January and August 2022 in three areas of a large urban safety net hospital. Setting: A large single academic medical center. Participants: Emergency department, inpatient clinicians, and procedural areas. The subjects of the study were trainees, attending physicians, and advance practice providers (APPs) Interventions: Data were collected from the participants using a self-reported questionnaire, including sociodemographic characteristics, ease of use, reliability, and preference. Additionally, the perception of the strengths and limitations associated with electronic prescribing (e-prescribing) were analyzed. Main outcome measure: The purpose of this study was to evaluate the barriers to e-prescribing of opioids. Results: A total of 121 prescribers completed the survey. The majority trusted that e-prescribing were transmitted successfully (62 percent), saved time (78 percent), and did not interrupt their workflow (78 percent). However, many prescribers indicated that additional improvements are needed, such as updating the patient’s preferred pharmacy in the electronic medical record during each visit (52 percent) and having a 24-hour pharmacy readily available (66 percent). Conclusion: Prescribers value the ease of use of e-prescribing and how time efficient the process can be. Nevertheless, there is a need to improve the system’s service, design, and usefulness.  

Publisher

Weston Medical Publishing

Reference24 articles.

1. US Department of Health and Human Services: Opioid abuse in the US and HHS actions to address opioid-drug related overdoses and deaths. ASPE: Office of the Assistant Secretary for Planning and Evaluation. Available at https://aspe.hhs.gov/reports/opioid-abuse-us-hhs-actions-address-opioid-drugrelated-overdoses-deaths-0. Accessed July 7, 2023.

2. Balyan R, Hahn D, Huang H, et al.: Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic. Expert Opin Drug Metabol Toxicol. 2020; 16(2): 125-141.

3. Centers for Disease Control and Prevention: Provisional data shows US drug overdose deaths top 100,000 in 2022. Available at https://blogs.cdc.gov/nchs/2023/05/18/7365/. Accessed July 7, 2023.

4. Everson J, Cheng AK, Patrick SW, et al.: Association of electronic prescribing of controlled substances with opioid prescribing rates. JAMA Netw Open. 2020; 3(12): e2027951.

5. HHS Centers for Medicare & Medicaid Services 2020: Medicare program: Electronic prescribing of controlled substances

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3